Abstract:Beyond the essential role of p27Kip1 and cyclin D2 in cell cycle progression, they are also shown to confer an anti-apoptotic function in peripheral blood (PB) lymphocytes. Although the aberrant longevity and expression of p27Kip1 and cyclin D2 in leukemic cells is well documented, the exact mechanisms responsible for this phenomenon have yet to be elucidated. This study was undertaken to determine the associations between polymorphisms in the CDKN1B and CCND2 genes (encoding p27Kip1 and cyclin D2, respectively) and susceptibility to chronic lymphocytic leukemia (CLL), as well as their influence on the expression of both cell cycle regulators in PB leukemic B cells and non-malignant T cells from untreated CLL patients divided according to the genetic determinants studied. Three CDKN1B single-nucleotide polymorphisms (SNPs), rs36228499, rs34330, and rs2066827, and three CCND2 SNPs, rs3217933, rs3217901, and rs3217810, were genotyped using a real-time PCR system. The expression of p27Kip1 and cyclin D2 proteins in both leukemic B cells and non-malignant T cells was determined using flow cytometry. We found that the rs36228499A and rs34330T alleles in CDKN1B and the rs3217810T allele in the CCND2 gene were more frequent in patients and were associated with increased CLL risk. Moreover, we observed that patients possessing the CCND2rs3217901G allele had lower susceptibility to CLL (most pronounced in the AG genotype). We also noticed that the presence of the CDKN1Brs36228499CC, CDKN1Brs34330CC, CDKN1Brs2066827TT, and CCND2rs3217901AG genotypes shortened the time to CLL progression. Statistically significant functional relationships were limited to T cells and assigned to CDKN1B polymorphic variants; carriers of the polymorphisms rs34330CC and rs36228499CC (determining the aggressive course of CLL) expressed a decrease in p27Kip1 and cyclin D2 levels, respectively. We indicate for the first time that genetic variants at the CDKN1B and CCND2 loci may be considered as a potentially low-penetrating risk factor for CLL and determining the clinical outcome.

Crohn's Disease Candidate Gene Alleles Predict Time to Progression from Inflammatory B1 to Stricturing B2, or Penetrating B3 Phenotype.

Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort

Association of Polymorphisms in the IL‐10 Promoter Region with Crohn's Disease

Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease

Prediction of Crohn’s Disease Stricturing Phenotype Using a NOD2-derived Genomic Biomarker

TNFSF15 Variant Predicts Disease Progression in Chinese Patients with Crohn’s Disease

Heterozygous variants of NOD2, IL10RA, PLA2G6 and COL7A1 correlate with Crohn's disease

Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort

Identification of Targets for Subsequent Treatment of Crohn's Disease Patients after Failure of Anti-TNF Therapy.

The Genetics of Crohn's Disease

Research progress of Crohn's disease related genes

[NOD2/CARD15 Gene Polymorphisms and Susceptibility to Crohn's Disease in Chinese Han Population].

P699 Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT Study

Vitamin D Metabolism-related Gene Polymorphisms in Crohn's Disease

The Association of Leptin Gene Polymorphisms with Crohn's Disease in a Chinese Pediatric Population

Association Between HLA-Cw Polymorphism and Inflammatory Bowel Disease

Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis

Exome Sequencing Detect Potential Susceptibility Gene Mutations In Chinese Crohn'S Disease Patient

Predictive parameters for the clinical course of Crohn’s disease: development of a simple and reliable risk model

Su1766 Phenotype of Peripheral T Lymphocyte Did Not Correlate with Genotype at Rs7746082, a Confirmed Focal SNP on 6q21 for Crohn's Disease Susceptibility

Association of Genetic Variants at the CDKN1B and CCND2 Loci Encoding p27Kip1 and Cyclin D2 Cell Cycle Regulators with Susceptibility and Clinical Course of Chronic Lymphocytic Leukemia